Treatment for American Tegumentary Leishmaniasis with N-Methylglucamine Antimoniate: Hearing and College Events
Introduction: American cutaneous leishmaniasis (ACL) is a noncontagious disease, a chronic disease that affects the skin and cartilaginous structures of the nasopharynx localized or diffuse. Treatment of ACL is a challenge because the available drugs have high toxicity (nephrotoxicity, hepatotoxicity, and cardiotoxicity) and none of them are quite effective.
Objective: This study aims to determine through historical survey auditory and vestibular manifestations of subjects affected by ACL during treatment with the drug Glucantime.
Methods: A protocol with an audiological history of the subjects were used.
Results: Out of the subjects surveyed (55.6%) were males and (44.4%) were females. Among the auditory and vestibular symptoms, 33.3% reported difficulty in hearing, 33.3% reported tinnitus, and 11.1% reported dizziness. By linking auditory symptoms with medication used in the treatment of ACL 11.1% had such a relationship.
Conclusion: It is emphasized that these results are descriptive and need a larger sample so you can say that it is reproducible and have applicable results to the general population. However, it is important to note the inclusion of professionals in the field of speech in outpatient surveillance because treatment success should be linked to a concern for the well-being and quality of life of the individual in treatment, which includes hearing care.